InsideTracker

company

About

InsideTracker features its platform that analyzes and tracks key biochemical and physiological markers.

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
$15M
Industries
Analytics,Biotechnology,Fitness,Health Care,Wellness
Founded date
Jun 1, 2009
Number Of Employee
11 - 50
Operating Status
Active

InsideTracker is a personalized health analytics company founded by leading scientists, physicians, nutritionists, and exercise physiologists from MIT, Harvard, and Tufts University. The InsideTracker platform analyzes and tracks key biochemical and physiological markers as they change over time. InsideTracker uses sophisticated algorithms and large scientific databases to determine optimal zones for each user’s markers. InsideTracker’s expert system then provides science-driven lifestyle and nutrition interventions that empower people to optimize their markers. When optimized, these marker levels have been scientifically proven to increase vitality, improve performance and extend life.

Its vision is to extend the quality and duration of human life by empowering individuals with the information they need to manage and optimize their own health. We believe that by providing a dynamic, personalized analytic platform at the intersection of biology, science and technology, then distilling the results into simple, natural and sustainable paths for people to follow, we can increase vitality, improve performance and extend the life of every person who is committed to achieving their full potential.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$15M
InsideTracker has raised a total of $15M in funding over 2 rounds. Their latest funding was raised on Sep 8, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 8, 2022 Series B $15M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
InsideTracker is funded by 1 investors. OurCrowd are the most recent investors.
Investor Name Lead Investor Funding Round
OurCrowd Series B